ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 166 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $22,745,000 | +7.8% | 638,000 | 0.0% | 0.10% | +10.5% |
Q3 2015 | $21,099,000 | -21.2% | 638,000 | -0.2% | 0.10% | -9.5% |
Q2 2015 | $26,766,000 | +35.3% | 639,100 | +5.3% | 0.10% | +36.4% |
Q1 2015 | $19,785,000 | +25.2% | 607,100 | +22.0% | 0.08% | +22.2% |
Q4 2014 | $15,797,000 | +27.1% | 497,530 | -0.9% | 0.06% | +23.5% |
Q3 2014 | $12,432,000 | +25.9% | 502,100 | +14.9% | 0.05% | +30.8% |
Q2 2014 | $9,872,000 | -17.6% | 437,000 | -11.3% | 0.04% | -20.4% |
Q1 2014 | $11,981,000 | – | 492,442 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |